BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aller MA, Arias JL, Cruz A, Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model 2007;4:44. [PMID: 17999758 DOI: 10.1186/1742-4682-4-44] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Aller M, Vara E, García C, Méndez M, Méndez-lópez M, Mejía I, López L, Arias J, Arias J. Prehepatic portal hypertension worsens the enterohepatic redox balance in thioacetamide-cirrhotic rats. Pathophysiology 2008;15:233-42. [DOI: 10.1016/j.pathophys.2008.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Arias N, Fidalgo C, Felipo V, Arias JL. The effects of hyperammonemia in learning and brain metabolic activity. Metab Brain Dis 2014;29:113-20. [PMID: 24415107 DOI: 10.1007/s11011-013-9477-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Aller MA, Arias JL, Arias J. The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. J Transl Med 2007;5:44. [PMID: 17892556 DOI: 10.1186/1479-5876-5-44] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
4 Yi Z, Zhang M, Ma Z, Tuo B, Liu A, Deng Z, Zhao Y, Li T, Liu X. Role of the posterior mucosal defense barrier in portal hypertensive gastropathy. Biomed Pharmacother 2021;144:112258. [PMID: 34614465 DOI: 10.1016/j.biopha.2021.112258] [Reference Citation Analysis]
5 Van Steenkiste C, Geerts A, Vanheule E, Van Vlierberghe H, De Vos F, Olievier K, Casteleyn C, Laukens D, De Vos M, Stassen JM, Carmeliet P, Colle I. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension. Gastroenterology. 2009;137:2112-24.e1-6. [PMID: 19751735 DOI: 10.1053/j.gastro.2009.08.068] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
6 Blanco-Rivero J, Aller MA, Arias J, Ferrer M, Balfagón G. Long-term portal hypertension increases the vasodilator response to acetylcholine in rat aorta: role of prostaglandin I2. Clin Sci (Lond). 2009;117:365-374. [PMID: 19331646 DOI: 10.1042/cs20080499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
7 Iguchi H, Oda M, Yamazaki H, Yoshimura K, Ando W, Yokomori H. Aquaporin-1 is associated with arterial capillary proliferation and hepatic sinusoidal transformation contributing to portal hypertension in primary biliary cirrhosis. Med Mol Morphol. 2014;47:90-99. [PMID: 23949237 DOI: 10.1007/s00795-013-0048-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Hu MD, Guo GH. Advances in research on portal hypertensive enteropathy. Shijie Huaren Xiaohua Zazhi 2009; 17(20): 2054-2057 [DOI: 10.11569/wcjd.v17.i20.2054] [Reference Citation Analysis]
9 Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
10 Moon C, Oh C, Ahn K, Yang J, Kim J, Shin S, Lim H, Heo S, Seon H, Kim J, Jeong G. Metabolic biomarkers for non-alcoholic fatty liver disease induced by high-fat diet: In vivo magnetic resonance spectroscopy of hyperpolarized [1-13C] pyruvate. Biochemical and Biophysical Research Communications 2017;482:112-9. [DOI: 10.1016/j.bbrc.2016.08.118] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
11 Kumar R, Anand U, Priyadarshi RN. Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications. World J Hepatol 2021; 13(3): 300-314 [PMID: 33815674 DOI: 10.4254/wjh.v13.i3.300] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Aller MA, Blanco-Rivero J, Arias N, Santamaria L, Arias J. The Lymphatic Headmaster of the Mast Cell-Related Splanchnic Inflammation in Portal Hypertension. Cells 2019;8:E658. [PMID: 31261968 DOI: 10.3390/cells8070658] [Reference Citation Analysis]
13 Aller MA, Arias N, Blanco-Rivero J, Arias J. Metabolism in Acute-On-Chronic Liver Failure: The Solution More than the Problem. Arch Med Res 2019;50:271-84. [PMID: 31593852 DOI: 10.1016/j.arcmed.2019.09.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Gilsanz C, Aller MA, Fuentes-Julian S, Prieto I, Blázquez-Martinez A, Argudo S, Fernández-Delgado J, Beleña J, Arias J, De Miguel MP. Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure. Biomed Pharmacother 2017;91:776-87. [PMID: 28501004 DOI: 10.1016/j.biopha.2017.04.117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
15 Aller MA, Arias N, Blanco-Rivero J, Balfagón G, Arias J. Portal hypertension: The desperate search for the placenta. Curr Res Transl Med 2019;67:56-61. [PMID: 30503816 DOI: 10.1016/j.retram.2018.09.001] [Reference Citation Analysis]
16 Aller MA, Arias JL, Prieto I, Losada M, Arias J. Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis. Eur J Gastroenterol Hepatol 2010;22:651-61. [PMID: 19641467 DOI: 10.1097/MEG.0b013e32832e0a2f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
17 Aller M, Mendez M, Nava M, Lopez L, Arias J, Arias J. The value of microsurgery in liver research. Liver International 2009;29:1132-40. [DOI: 10.1111/j.1478-3231.2009.02078.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
18 Aller MA, Arias JI, Alonso-Poza A, Arias J. A review of metabolic staging in severely injured patients. Scand J Trauma Resusc Emerg Med 2010;18:27. [PMID: 20478066 DOI: 10.1186/1757-7241-18-27] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
19 Aller MÁ, Martínez V, Arias A, Nava MP, Cuervas-Mons V, Vergara P, Arias J. Mast cell-mediated splanchnic cholestatic inflammation. Clin Res Hepatol Gastroenterol 2019;43:561-74. [PMID: 30853494 DOI: 10.1016/j.clinre.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Adar T, Edden Y, Shteingart S, Ben Ya’acov A, Mahamid M, Broide E, Shmorak S, Bar-gil Shitrit A, Reinus C, Goldin E. Portal hypertension is associated with modulation of regulatory T cells. Eur J Inflamm 2016;14:40-7. [DOI: 10.1177/1721727x15622960] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 García-Dominguez J, Aller MA, García C, de Vicente F, Corcuera MT, Gómez-Aguado F, Alonso MJ, Vara E, Arias J. Splanchnic Th(2) and Th(1) cytokine redistribution in microsurgical cholestatic rats. J Surg Res 2010;162:203-12. [PMID: 20031157 DOI: 10.1016/j.jss.2009.06.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Norman K, Pirlich M. Gastrointestinal tract in liver disease: which organ is sick? Curr Opin Clin Nutr Metab Care. 2008;11:613-619. [PMID: 18685458 DOI: 10.1097/mco.0b013e32830a70bc] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
23 Jeon SR, Kim JO. Capsule Endoscopy for Portal Hypertensive Enteropathy. Gastroenterol Res Pract 2016;2016:8501394. [PMID: 26819613 DOI: 10.1155/2016/8501394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Aller MA, Arias JI, Arias J. Pathological axes of wound repair: gastrulation revisited. Theor Biol Med Model. 2010;7:37. [PMID: 20840764 DOI: 10.1186/1742-4682-7-37] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
25 de Las Heras N, Aller MA, Martín-Fernández B, Miana M, Ballesteros S, Regadera J, Cachofeiro V, Arias J, Lahera V. A wound-like inflammatory aortic response in chronic portal hypertensive rats. Mol Immunol. 2012;51:177-187. [PMID: 22463791 DOI: 10.1016/j.molimm.2012.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
26 Sánchez-patán F, Aller M, Cuellar C, Rodero M, Corcuera M, Nava M, Gómez F, Blanco M, Guerrero S, Anchuelo R, Muñiz E, Alonso M, Teijón J, Arias J. Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats. Experimental and Toxicologic Pathology 2008;60:347-55. [DOI: 10.1016/j.etp.2008.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
27 Bouabdallaoui N, Sirois MG, Beaubien-Souligny W, Denault AY, Rouleau JL. Lymphocytopenia During Hospitalization for Acute Heart Failure and Its Relationship With Portal Congestion and Right Ventricular Function. J Card Fail 2020;26:1043-9. [PMID: 32659436 DOI: 10.1016/j.cardfail.2020.07.001] [Reference Citation Analysis]
28 Tan S, Xu M, Ke B, Lu Y, Liu H, Jiang J, Wu B. IL-6-driven FasL promotes NF-κBp65/PUMA-mediated apoptosis in portal hypertensive gastropathy. Cell Death Dis 2019;10:748. [PMID: 31582729 DOI: 10.1038/s41419-019-1954-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Montomoli J, Holland-Fischer P, Bianchi G, Grønbæk H, Vilstrup H, Marchesini G, Zoli M. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2010; 16(3): 348-353 [PMID: 20082481 DOI: 10.3748/wjg.v16.i3.348] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
30 Aller MA, Prieto I, Argudo S, de Vicente F, Santamaría L, de Miguel MP, Arias JL, Arias J. The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea. Int J Inflam. 2010;2010:148689. [PMID: 21152120 DOI: 10.4061/2010/148689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
31 Aller MA, Heras NL, Nava MP, Regadera J, Arias J, Lahera V. Splanchnic-aortic inflammatory axis in experimental portal hypertension. World J Gastroenterol 2013; 19(44): 7992-7999 [PMID: 24307792 DOI: 10.3748/wjg.v19.i44.7992] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
32 Aller MA, Arias N, Prieto I, Agudo S, Gilsanz C, Lorente L, Arias JL, Arias J. A half century (1961-2011) of applying microsurgery to experimental liver research. World J Hepatol 2012; 4(7): 199-208 [PMID: 22855695 DOI: 10.4254/wjh.v4.i7.199] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
33 Tsai H, Li T, Huang C, Huang S, Liu R, Yang Y, Hsieh Y, Lee K, Huang Y, Hou M, Lin H. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension. The American Journal of Pathology 2018;188:1608-24. [DOI: 10.1016/j.ajpath.2018.03.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
34 Basei FL, Cabrini DA, Figueiredo CP, Forner S, Hara DB, Nascimento AF, Ceravolo GS, Carvalho MHC, Bader M, Medeiros R, Calixto JB. Endothelium dependent expression and underlying mechanisms of des-Arg9-bradykinin-induced B1R-mediated vasoconstriction in rat portal vein. Peptides 2012;37:216-24. [DOI: 10.1016/j.peptides.2012.07.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
35 Aller MA, Heras N, Blanco-Rivero J, Arias JI, Lahera V, Balfagón G, Arias J. Portal hypertensive cardiovascular pathology: the rescue of ancestral survival mechanisms? Clin Res Hepatol Gastroenterol 2012;36:35-46. [PMID: 22264837 DOI: 10.1016/j.clinre.2011.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
36 Aller MA, Arias JL, García-Domínguez J, Arias JI, Durán M, Arias J. Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair. 2008;1:6. [PMID: 19014418 DOI: 10.1186/1755-1536-1-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
37 Xavier FE, Blanco-Rivero J, Sastre E, Badimón L, Balfagón G. Simultaneous inhibition of TXA(2) and PGI(2) synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats. Clin Sci (Lond). 2010;119:283-292. [PMID: 20459396 DOI: 10.1042/CS20090536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
38 García C, Gine E, Aller M, Revuelta E, Arias J, Vara E, Arias J. Multiple organ inflammatory response to portosystemic shunt in the rat. Cytokine 2011;56:680-7. [DOI: 10.1016/j.cyto.2011.08.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
39 Manti S, Marseglia L, D’Angelo G, Filippelli M, Cuppari C, Gitto E, Romano C, Arrigo T, Salpietro C. Portal hypertension as immune mediate disease. Hepat Mon. 2014;14:e18625. [PMID: 24976841 DOI: 10.5812/hepatmon.18625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Aller M, Martinez V, Corcuera M, Benito J, Traver E, Gómez-aguado F, Vergara P, Arias J. Liver impairment after portacaval shunt in the rat: The loss of protective role of mast cells? Acta Histochemica 2012;114:301-10. [DOI: 10.1016/j.acthis.2011.06.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Merino J, Aller MA, Rubio S, Arias N, Nava MP, Loscertales M, Arias J, Arias JL. Gut-brain chemokine changes in portal hypertensive rats. Dig Dis Sci. 2011;56:2309-2317. [PMID: 21347560 DOI: 10.1007/s10620-011-1625-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]